logo-loader

Invitrocue signs agreement to develop new breast cancer models for its Onco-PDO test

Published: 06:11 23 Jan 2019 GMT

a woman holding a ribbon
Evidence-based approach to inform treatment pathways

Invitrocue Ltd (ASX:IVQ) has signed a new technology development agreement with the Shanghai Institute of Biochemistry and Cell Biology (SIBCB) for the development of new breast cancer models for its proprietary Onco-PDO test.

The Onco-PDO technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support clinical decision making for individual patients.

 

 

Under the agreement, professor Arial Zeng, an expert in stem cells during mammary development and breast cancer, will help Invitrocue to develop and optimise the protocols for the in vitro culture, propagation and expansion of patient-derived organoids (PDOs) from breast cancer patients with multiple breast cancer subtypes, including ER+, PR+, HER2+ and TNBC.

The intellectual property (IP) will be jointly owned by both parties and Invitrocue will be granted global commercialisation rights to any IP developed under the agreement.

Invitrocue executive chairman Dr. Steven Fang said: “Whilst we already offer breast cancer testing with Onco-PDOTM, this collaboration agreement is an important advancement of our technology to expand into multiple subtypes of the world’s leading cancer for women.

“Professor Arial Zeng is a world-renowned scientist in breast cancer organoid biology, and we look forward to working closely with her.

“This collaboration will enable us to provide even more precise and personalised data for breast cancer patients, leveraging our evidence-based approach to inform treatment pathways and improve patient outcomes.”

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

2 hours, 1 minute ago